{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:22:09Z","timestamp":1792790529444,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatic steatosis is the main characteristic of some liver metabolism diseases. However, unclear molecular mechanism of hepatic steatosis impedes the therapy of this hepatic steatosis. Glutathione-S-transferase mu 2 (<jats:italic>GSTM2<\/jats:italic>), as a member of phase II drug metabolizing enzymes (DMEs), regulates cellular antioxidant and detoxificant.<jats:italic>GSTM2<\/jats:italic>was highly up-regulated in hepatic steatosis tissues and high-fat diet (HFD) fed mice. Loss-of-function<jats:italic>GSTM2<\/jats:italic>mouse model demonstrated that<jats:italic>GSTM2<\/jats:italic>protected mice from excess fat accumulation. Mechanistically,<jats:italic>GSTM2<\/jats:italic>interacted with ASK1 and suppressed its phosphorylation and the activation of subsequent downstream p38-JNK signalling. Moreover,<jats:italic>GSTM2<\/jats:italic>overexpression in the liver effectively ameliorated hepatic lipid accumulation. Therefore, we identified<jats:italic>GSTM2<\/jats:italic>as an important negative regulator in progression of hepatic steatosis via both its detoxification\/antioxidant and inhibition of ASK1-p38\/JNK signalling. This study showed potential therapeutic function of the DME in progression of hepatic steatosis.<\/jats:p>","DOI":"10.1038\/s42003-022-03251-w","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T10:08:13Z","timestamp":1649239693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Glutathione S-transferase Mu 2 inhibits hepatic steatosis via ASK1 suppression"],"prefix":"10.1038","volume":"5","author":[{"given":"Yi","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4600-5312","authenticated-orcid":false,"given":"Zhuqing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,6]]},"reference":[{"key":"3251_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3727\/105221616X692135","volume":"17","author":"MD Thompson","year":"2016","unstructured":"Thompson, M. D. et al. Enhanced steatosis and fibrosis in liver of adult offspring exposed to maternal high-fat diet. Gene Expr. 17, 47\u201359 (2016).","journal-title":"Gene Expr."},{"key":"3251_CR2","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1007\/s10620-016-4143-0","volume":"61","author":"ZA Sherif","year":"2016","unstructured":"Sherif, Z. A. et al. Global epidemiology of nonalcoholic fatty liver disease and perspectives on US minority populations. Dig. Dis. Sci. 61, 1214\u20131225 (2016).","journal-title":"Dig. Dis. Sci."},{"key":"3251_CR3","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","volume":"10","author":"R Loomba","year":"2013","unstructured":"Loomba, R. & Sanyal, A. J. The global NAFLD epidemic. Nat. Rev. Gastro Hepat. 10, 686\u2013690 (2013).","journal-title":"Nat. Rev. Gastro Hepat."},{"key":"3251_CR4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1023\/A:1007579507804","volume":"25","author":"CT Beuckmann","year":"2000","unstructured":"Beuckmann, C. T., Fujimori, K., Urade, Y. & Hayaishi, O. Identification of Mu-class glutathione transferases M2-2 and M3-3 as cytosolic prostaglandin E synthases in the human brain. Neurochem. Res. 25, 733\u2013738 (2000).","journal-title":"Neurochem. Res."},{"key":"3251_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1042\/bj20020320","volume":"365","author":"SA Chanas","year":"2002","unstructured":"Chanas, S. A. et al. Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochem. J. 365, 405\u2013416 (2002).","journal-title":"Biochem. J."},{"key":"3251_CR6","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.carbpol.2016.10.042","volume":"157","author":"X Si","year":"2017","unstructured":"Si, X., Strappe, P., Blanchard, C. & Zhou, Z. Enhanced anti-obesity effects of complex of resistant starch and chitosan in high fat diet fed rats. Carbohydr. Polym. 157, 834\u2013841 (2017).","journal-title":"Carbohydr. Polym."},{"key":"3251_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.etap.2016.05.014","volume":"45","author":"C Wang","year":"2016","unstructured":"Wang, C., Tao, Q., Wang, X., Wang, X. & Zhang, X. Impact of high-fat diet on liver genes expression profiles in mice model of nonalcoholic fatty liver disease. Environ. Toxicol. Pharmacol. 45, 52\u201362 (2016).","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"3251_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.lfs.2015.11.014","volume":"144","author":"K Saify","year":"2016","unstructured":"Saify, K., Saadat, I. & Saadat, M. Down-regulation of antioxidant genes in human SH-SY5Y cells after treatment with morphine. Life Sci. 144, 26\u201329 (2016).","journal-title":"Life Sci."},{"key":"3251_CR9","doi-asserted-by":"publisher","first-page":"618","DOI":"10.4161\/auto.27720","volume":"10","author":"S Huenchuguala","year":"2014","unstructured":"Huenchuguala, S. et al. Glutathione transferase mu 2 protects glioblastoma cells against aminochrome toxicity by preventing autophagy and lysosome dysfunction. Autophagy. 10, 618\u2013630 (2014).","journal-title":"Autophagy."},{"key":"3251_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12640-014-9500-1","volume":"27","author":"C Cuevas","year":"2015","unstructured":"Cuevas, C. et al. Glutathione transferase-M2-2 secreted from glioblastoma cell protects SH-SY5Y cells from aminochrome neurotoxicity. Neurotox. Res 27, 217\u2013228 (2015).","journal-title":"Neurotox. Res"},{"key":"3251_CR11","doi-asserted-by":"crossref","unstructured":"Huenchuguala, S., Mu\u00f1oz, P. & Seguraaguilar, J. The importance of mitophagy in maintaining mitochondrial function in U373MG cells. bafilomycin a1 restores aminochrome-induced mitochondrial damage. Acs Chem. Neurosci. 8, 2247\u20132253 (2017).","DOI":"10.1021\/acschemneuro.7b00152"},{"key":"3251_CR12","doi-asserted-by":"publisher","first-page":"e12611","DOI":"10.1111\/jpi.12611","volume":"67","author":"DJ Li","year":"2019","unstructured":"Li, D. J. et al. Melatonin safeguards against fatty liver by antagonizing TRAFs-mediated ASK1 deubiquitination and stabilization in a beta-arrestin-1 dependent manner. J. pineal Res. 67, e12611 (2019).","journal-title":"J. pineal Res."},{"key":"3251_CR13","doi-asserted-by":"publisher","first-page":"30792","DOI":"10.1074\/jbc.M203642200","volume":"277","author":"S Dorion","year":"2002","unstructured":"Dorion, S., Lambert, H. & Landry, J. Activation of the p38 signaling pathway by heat shock involves the dissociation of glutathione S-transferase Mu from Ask1. J. Biol. Chem. 277, 30792 (2002).","journal-title":"J. Biol. Chem."},{"key":"3251_CR14","doi-asserted-by":"publisher","first-page":"12749","DOI":"10.1074\/jbc.M005561200","volume":"276","author":"SG Cho","year":"2001","unstructured":"Cho, S. G. et al. Glutathione S-transferase Mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J. Biol. Chem. 276, 12749\u201312755 (2001).","journal-title":"J. Biol. Chem."},{"key":"3251_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ccr.2006.12.013","volume":"11","author":"I Dolado","year":"2007","unstructured":"Dolado, I. et al. p38 alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell. 11, 191\u2013205 (2007).","journal-title":"Cancer Cell."},{"key":"3251_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cell.2014.12.019","volume":"160","author":"L Liu","year":"2015","unstructured":"Liu, L. et al. Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration. Cell. 160, 177\u2013190 (2015).","journal-title":"Cell."},{"key":"3251_CR17","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.bbrc.2015.10.052","volume":"467","author":"T Kurahashi","year":"2015","unstructured":"Kurahashi, T. et al. An SOD1 deficiency enhances lipid droplet accumulation in the fasted mouse liver by aborting lipophagy. Biochem. Biophys. Res. Commun. 467, 866\u2013871 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"3251_CR18","doi-asserted-by":"publisher","first-page":"e01607","DOI":"10.7554\/eLife.01607","volume":"3","author":"F Wilfling","year":"2013","unstructured":"Wilfling, F. et al. Arf1\/COPI machinery acts directly on lipid droplets and enables their connection to the ER for protein targeting. ELife. 3, e01607 (2013).","journal-title":"ELife."},{"key":"3251_CR19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nature06928","volume":"453","author":"Y Guo","year":"2008","unstructured":"Guo, Y. et al. Functional genomic screen reveals genes involved in lipid-droplet formation and utilization. Nature. 453, 657\u2013661 (2008).","journal-title":"Nature."},{"key":"3251_CR20","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.cmet.2011.07.013","volume":"14","author":"N Krahmer","year":"2011","unstructured":"Krahmer, N. et al. Phosphatidylcholine Synthesis for lipid droplet expansion is mediated by localized activation of CTP:phosphocholine cytidylyltransferase. Cell Metab. 14, 504\u2013515 (2011).","journal-title":"Cell Metab."},{"key":"3251_CR21","doi-asserted-by":"publisher","first-page":"39107","DOI":"10.1074\/jbc.M112.412569","volume":"287","author":"XW Xiong","year":"2012","unstructured":"Xiong, X. W., Tao, R. Y., DePinho, R. A. & Dong, X. C. The autophagy-related gene 14 (Atg14) is regulated by forkhead box o transcription factors and circadian rhythms and plays a critical role in hepatic autophagy and lipid metabolism. J. Biol. Chem. 287, 39107\u201339114 (2012).","journal-title":"J. Biol. Chem."},{"key":"3251_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.cmet.2010.04.005","volume":"11","author":"L Yang","year":"2010","unstructured":"Yang, L., Li, P., Fu, S. N., Calay, E. S. & Hotamisligil, G. S. Defective hepatic autophagy in obesity promotes er stress and causes insulin resistance. Cell Metab. 11, 467\u2013478 (2010).","journal-title":"Cell Metab."},{"key":"3251_CR23","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1124\/dmd.110.036806","volume":"39","author":"P Li","year":"2011","unstructured":"Li, P. et al. Hepatic pharmacokinetics of cationic drugs in a high-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Drug Metab. Dispos. 39, 571\u2013579 (2011).","journal-title":"Drug Metab. Dispos."},{"key":"3251_CR24","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.3748\/wjg.15.2817","volume":"15","author":"G Tarantino","year":"2009","unstructured":"Tarantino, G., Di Minno, M. N. D. & Capone, D. Drug-induced liver injury: is it somehow foreseeable? World J. Gastro. 15, 2817\u20132833 (2009).","journal-title":"World J. Gastro."},{"key":"3251_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejphar.2009.04.002","volume":"613","author":"CD Fisher","year":"2009","unstructured":"Fisher, C. D. et al. Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats. Eur. J. Pharm. 613, 119\u2013127 (2009).","journal-title":"Eur. J. Pharm."},{"key":"3251_CR26","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1124\/jpet.107.124024","volume":"322","author":"WV Zhang","year":"2007","unstructured":"Zhang, W. V., Ramzan, I. & Murray, M. Impaired microsomal oxidation of the atypical antipsychotic agent clozapine in hepatic steatosis. J. Pharm. Exp. Ther. 322, 770\u2013777 (2007).","journal-title":"J. Pharm. Exp. Ther."},{"key":"3251_CR27","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1872-034X.2007.00072.x","volume":"37","author":"G Tarantino","year":"2007","unstructured":"Tarantino, G. et al. A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease. Hepatol. Res. 37, 410\u2013415 (2007).","journal-title":"Hepatol. Res."},{"key":"3251_CR28","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.molmed.2006.10.001","volume":"12","author":"LA Videla","year":"2006","unstructured":"Videla, L. A., Rodrigo, R., Araya, J. & Poniachik, J. Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease. Trends Mol. Med. 12, 555\u2013558 (2006).","journal-title":"Trends Mol. Med."},{"key":"3251_CR29","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1177\/108155890405200822","volume":"52","author":"S Gawrieh","year":"2004","unstructured":"Gawrieh, S., Opara, E. C. & Koch, T. R. Oxidative stress in nonalcoholic fatty liver disease: Pathogenesis and antioxidant therapies. J. Invest Med. 52, 506\u2013514 (2004).","journal-title":"J. Invest Med."},{"key":"3251_CR30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1042\/CS20030285","volume":"106","author":"LA Videla","year":"2004","unstructured":"Videla, L. A. et al. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin. Sci. 106, 261\u2013268 (2004).","journal-title":"Clin. Sci."},{"key":"3251_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.bbrc.2015.06.121","volume":"464","author":"J Lee","year":"2015","unstructured":"Lee, J., Homma, T., Kurahashi, T., Kang, E. S. & Fujii, J. Oxidative stress triggers lipid droplet accumulation in primary cultured hepatocytes by activating fatty acid synthesis. Biochem. Biophys. Res. Commun. 464, 229\u2013235 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"3251_CR32","doi-asserted-by":"crossref","unstructured":"Li, Y. J. et al. Glutathione S-transferase Mu 2-transduced mesenchymal stem cells ameliorated anti-glomerular basement membrane antibody-induced glomerulonephritis by inhibiting oxidation and inflammation. Stem Cell Res. Ther. 5, 19 (2014).","DOI":"10.1186\/scrt408"},{"key":"3251_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/srep02704","volume":"3","author":"P Bhattacharjee","year":"2013","unstructured":"Bhattacharjee, P. et al. Functional compensation of glutathione S-transferase M1 (GSTM1) null by another GST superfamily member, GSTM2. Sci. Rep. 3, 2704 (2013).","journal-title":"Sci. Rep."},{"key":"3251_CR34","doi-asserted-by":"crossref","unstructured":"Sun, P. et al. Caspase recruitment domain protein 6 protects against hepatic steatosis and insulin resistance by suppressing Ask1. Hepatology. 68, 2212\u20132229 (2018).","DOI":"10.1002\/hep.30075"},{"key":"3251_CR35","doi-asserted-by":"crossref","unstructured":"Ye, P. et al. Dual-specificity Phosphatase 9 Protects Against Non-alcoholic Fatty Liver Disease in Mice via ASK1 Suppression. Hepatology. 69, 76\u201393 (2018).","DOI":"10.1002\/hep.30198"},{"key":"3251_CR36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1128\/MCB.00503-14","volume":"35","author":"A Lawan","year":"2015","unstructured":"Lawan, A. et al. Hepatic mitogen-activated protein kinase phosphatase 1 selectively regulate glucose metabolism and energy homeostasis. Mol. Cell. Biol. 35, 26 (2015).","journal-title":"Mol. Cell. Biol."},{"key":"3251_CR37","doi-asserted-by":"crossref","unstructured":"Cingolani, F. & Czaja, M. J. Oxidized albumin\u2014a Trojan Horse for p38 MAPK-mediated Inflammation in decompensated Cirrhosis. Hepatology. 68,1678\u20131680 (2018).","DOI":"10.1002\/hep.30164"},{"key":"3251_CR38","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/hep.24357","volume":"54","author":"H Nakagawa","year":"2011","unstructured":"Nakagawa, H. et al. Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor-suppressing function of stress-activated mitogen-activated protein kinase. Hepatology. 54, 185\u2013195 (2011).","journal-title":"Hepatology."},{"key":"3251_CR39","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1002\/hep.29689","volume":"67","author":"S Win","year":"2017","unstructured":"Win, S. et al. New insights into the role and mechanism of c-Jun-N-terminal kinase signaling in the pathobiology of liver diseases. Hepatology. 67, 2013\u20132024 (2017).","journal-title":"Hepatology."},{"key":"3251_CR40","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/hep.29514","volume":"67","author":"R Loomba","year":"2018","unstructured":"Loomba, R. et al. The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: a randomized, phase 2 trial. Hepatology. 67, 549\u2013559 (2018).","journal-title":"Hepatology."},{"key":"3251_CR41","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrd.2017.60","volume":"16","author":"MT Villanueva","year":"2017","unstructured":"Villanueva, M. T. Liver disease: conscious uncoupling in NASH. Nat. Rev. Drug Discov. 16, 238 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"3251_CR42","doi-asserted-by":"crossref","unstructured":"Nishida, T., Hattori, K. & Watanabe, K. The regulatory and signaling mechanisms of the ASK family. Adv Biol. Regul. 66, 2\u201322 (2017).","DOI":"10.1016\/j.jbior.2017.05.004"},{"key":"3251_CR43","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/pmic.201000475","volume":"11","author":"I Han","year":"2011","unstructured":"Han, I. et al. Proteomic analysis of mesenchymal stem-like cells derived from ovarian teratoma: potential role of glutathione S-transferase M2 in ovarian teratoma. Proteomics. 11, 352\u2013360 (2011).","journal-title":"Proteomics."},{"key":"3251_CR44","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/sj.onc.1209373","volume":"25","author":"CC McIlwain","year":"2006","unstructured":"McIlwain, C. C., Townsend, D. M. & Tew, K. D. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene. 25, 1639\u20131648 (2006).","journal-title":"Oncogene."},{"key":"3251_CR45","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1126\/science.275.5296.90","volume":"275","author":"H Ichijo","year":"1997","unstructured":"Ichijo, H. et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK\/JNK and p38 signaling pathways. Science. 275, 90\u201394 (1997).","journal-title":"Science."},{"key":"3251_CR46","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1096\/fj.05-4376com","volume":"20","author":"CC Hsieh","year":"2006","unstructured":"Hsieh, C. C. & Papaconstantinou, J. Thioredoxin-ASK1 complex levels regulate ROS-mediated p38 MAPK pathway activity in livers of aged and long-lived Snell dwarf mice. Faseb J. 20, 259\u2013268 (2006).","journal-title":"Faseb J."},{"key":"3251_CR47","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba, R., Friedman, S. L. & Shulman, G. I. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 184, 2537\u20132564 (2021).","journal-title":"Cell."},{"key":"3251_CR48","doi-asserted-by":"publisher","first-page":"618","DOI":"10.4161\/auto.27720","volume":"10","author":"S Huenchuguala","year":"2014","unstructured":"Huenchuguala, S. et al. Glutathione transferase mu 2 protects glioblastoma cells against aminochrome toxicity by preventing autophagy and lysosome dysfunction. Autophagy. 10, 618\u2013630 (2014).","journal-title":"Autophagy."},{"key":"3251_CR49","doi-asserted-by":"crossref","unstructured":"Jin, Y., Tan, Y. J., Chen, L. P., Liu, Y. & Ren, Z. Q. Reactive oxygen species induces lipid droplet accumulation in HepG2 cells by increasing perilipin 2 expression. Int. J . Mol. Sci. 19, 3445 (2018).","DOI":"10.3390\/ijms19113445"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03251-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03251-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03251-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T20:13:07Z","timestamp":1675195987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-03251-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,6]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3251"],"URL":"https:\/\/doi.org\/10.1038\/s42003-022-03251-w","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,6]]},"assertion":[{"value":"9 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"326"}}